🧬 Endocrinology Update: AI Diagnoses T1D, DASH4D Lowers BP, Dual Sensor Tech Advances and More
From AI-powered diagnostics to dietary breakthroughs and hormone safety updates, this week’s endocrinology roundup brings you the most impactful news in diabetes care, thyroid health, and beyond.
📌 In This Episode:
✔️ A groundbreaking AI tool from Western Sydney University that transforms Type 1 diabetes diagnosis using microRNA biomarkers
✔️ How digital twin simulations are improving artificial pancreas performance
✔️ The Tandem-Abbott partnership pushing boundaries with dual glucose-ketone sensor tech
✔️ Titanium dioxide’s hidden risks in everyday snacks
✔️ The DASH4D diet’s real-world benefits for Type 2 diabetics
✔️ Latest research confirming the heart safety of testosterone therapy
✔️ Subclinical hypothyroidism in IT professionals linked to excessive screen time
✔️ Canada’s plan to replicate the U.K.’s successful diabetes prevention model
✔️ Why autoimmune conditions double the Type 1 diabetes risk in children
✔️ Dagliflozin’s renal protective role in diabetic kidney disease
📢 Stay Ahead in Endocrinology Research!
✅ Like, share, and subscribe for weekly updates on endocrinology, diabetes, PCOS, growth hormone, and more
#Endocrinology #DiabetesResearch #ArtificialPancreas #DigitalHealth #Type1Diabetes #Type2Diabetes #ThyroidHealth #DASHDiet #TestosteroneTherapy #Dagliflozin #HealthcareInnovation #LucidQuest #LQVentures